Skip to main content

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

Publication ,  Journal Article
Samimi, G; Bernardini, MQ; Brody, LC; Caga-Anan, CF; Campbell, IG; Chenevix-Trench, G; Couch, FJ; Dean, M; de Hullu, JA; Domchek, SM; Hurley, K ...
Published in: J Clin Oncol
July 10, 2017

In May 2016, the Division of Cancer Prevention and the Division of Cancer Control and Population Sciences, National Cancer Institute, convened a workshop to discuss a conceptual framework for identifying and genetically testing previously diagnosed but unreferred patients with ovarian cancer and other unrecognized BRCA1 or BRCA2 mutation carriers to improve the detection of families at risk for breast or ovarian cancer. The concept, designated Traceback, was prompted by the recognition that although BRCA1 and BRCA2 mutations are frequent in women with ovarian cancer, many such women have not been tested, especially if their diagnosis predated changes in testing guidelines. The failure to identify mutation carriers among probands represents a lost opportunity to prevent cancer in unsuspecting relatives through risk-reduction intervention in mutation carriers and to provide appropriate reassurances to noncarriers. The Traceback program could provide an important opportunity to reach families from racial, ethnic, and socioeconomic groups who historically have not sought or been offered genetic counseling and testing and thereby contribute to a reduction in health disparities in women with germline BRCA mutations. To achieve an interdisciplinary perspective, the workshop assembled international experts in genetics, medical and gynecologic oncology, clinical psychology, epidemiology, genomics, cost-effectiveness modeling, pathology, bioethics, and patient advocacy to identify factors to consider when undertaking a Traceback program. This report highlights the workshop deliberations with the goal of stimulating research and providing a framework for pilot studies to assess the feasibility and ethical and logistical considerations related to the development of best practices for implementation of Traceback studies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

July 10, 2017

Volume

35

Issue

20

Start / End Page

2329 / 2337

Location

United States

Related Subject Headings

  • Registries
  • Privacy
  • Pedigree
  • Patient Acceptance of Health Care
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Humans
  • Germ-Line Mutation
  • Genetic Testing
  • Genetic Counseling
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samimi, G., Bernardini, M. Q., Brody, L. C., Caga-Anan, C. F., Campbell, I. G., Chenevix-Trench, G., … Sherman, M. E. (2017). Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. J Clin Oncol, 35(20), 2329–2337. https://doi.org/10.1200/JCO.2016.70.3439
Samimi, Goli, Marcus Q. Bernardini, Lawrence C. Brody, Charlisse F. Caga-Anan, Ian G. Campbell, Georgia Chenevix-Trench, Fergus J. Couch, et al. “Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.J Clin Oncol 35, no. 20 (July 10, 2017): 2329–37. https://doi.org/10.1200/JCO.2016.70.3439.
Samimi G, Bernardini MQ, Brody LC, Caga-Anan CF, Campbell IG, Chenevix-Trench G, et al. Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. J Clin Oncol. 2017 Jul 10;35(20):2329–37.
Samimi, Goli, et al. “Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.J Clin Oncol, vol. 35, no. 20, July 2017, pp. 2329–37. Pubmed, doi:10.1200/JCO.2016.70.3439.
Samimi G, Bernardini MQ, Brody LC, Caga-Anan CF, Campbell IG, Chenevix-Trench G, Couch FJ, Dean M, de Hullu JA, Domchek SM, Drapkin R, Spencer Feigelson H, Friedlander M, Gaudet MM, Harmsen MG, Hurley K, James PA, Kwon JS, Lacbawan F, Lheureux S, Mai PL, Mechanic LE, Minasian LM, Myers ER, Robson ME, Ramus SJ, Rezende LF, Shaw PA, Slavin TP, Swisher EM, Takenaka M, Bowtell DD, Sherman ME. Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. J Clin Oncol. 2017 Jul 10;35(20):2329–2337.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

July 10, 2017

Volume

35

Issue

20

Start / End Page

2329 / 2337

Location

United States

Related Subject Headings

  • Registries
  • Privacy
  • Pedigree
  • Patient Acceptance of Health Care
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Humans
  • Germ-Line Mutation
  • Genetic Testing
  • Genetic Counseling